AU4167297A - Use of mutated macrolide binding protein for the prevention of guhd - Google Patents

Use of mutated macrolide binding protein for the prevention of guhd

Info

Publication number
AU4167297A
AU4167297A AU41672/97A AU4167297A AU4167297A AU 4167297 A AU4167297 A AU 4167297A AU 41672/97 A AU41672/97 A AU 41672/97A AU 4167297 A AU4167297 A AU 4167297A AU 4167297 A AU4167297 A AU 4167297A
Authority
AU
Australia
Prior art keywords
guhd
mutated
prevention
binding protein
macrolide binding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU41672/97A
Other languages
English (en)
Inventor
Peter J. Belshaw
Gerald Crabtree
Stuart L Schreiber
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Harvard College
Leland Stanford Junior University
Original Assignee
Harvard College
Leland Stanford Junior University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Harvard College, Leland Stanford Junior University filed Critical Harvard College
Publication of AU4167297A publication Critical patent/AU4167297A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0271—Chimeric vertebrates, e.g. comprising exogenous cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • C07K7/645—Cyclosporins; Related peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/90—Isomerases (5.)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Cell Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Environmental Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Toxicology (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Diabetes (AREA)
  • Animal Husbandry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU41672/97A 1996-08-27 1997-08-27 Use of mutated macrolide binding protein for the prevention of guhd Abandoned AU4167297A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2466696P 1996-08-27 1996-08-27
US60024666 1996-08-27
PCT/US1997/015153 WO1998008956A2 (fr) 1996-08-27 1997-08-27 Utilisation d'une proteine de fixation de macrolide mutee pour prevenir la reaction du greffon contre l'hote

Publications (1)

Publication Number Publication Date
AU4167297A true AU4167297A (en) 1998-03-19

Family

ID=21821767

Family Applications (1)

Application Number Title Priority Date Filing Date
AU41672/97A Abandoned AU4167297A (en) 1996-08-27 1997-08-27 Use of mutated macrolide binding protein for the prevention of guhd

Country Status (5)

Country Link
EP (1) EP0939822A2 (fr)
JP (1) JP2001527384A (fr)
AU (1) AU4167297A (fr)
CA (1) CA2263951A1 (fr)
WO (1) WO1998008956A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9812675D0 (en) * 1998-06-11 1998-08-12 Univ Edinburgh Peptides
WO2008132494A1 (fr) * 2007-05-01 2008-11-06 Ludwig Institute Of Cancer Research Variante tronquée de la mtor (cible de la rapamycine chez les mammifères)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE299145T1 (de) * 1994-08-18 2005-07-15 Ariad Gene Therapeutics Inc Neues multimerisierendes reagenz
US5723436A (en) * 1994-10-24 1998-03-03 The Board Of Trustees Of The Leland Stanford Junior University Calcineurin interacting protein compositions and methods

Also Published As

Publication number Publication date
EP0939822A2 (fr) 1999-09-08
WO1998008956A2 (fr) 1998-03-05
JP2001527384A (ja) 2001-12-25
CA2263951A1 (fr) 1998-03-05
WO1998008956A3 (fr) 1998-06-18

Similar Documents

Publication Publication Date Title
AU2330097A (en) Improved trocar
AU4922497A (en) Interleukin-18-receptor proteins
AU3387997A (en) Autonotification
AU2845197A (en) Cycloalkano-pyridines
AU5721798A (en) Human mage-like protein
AU7645496A (en) Roundsling construction
AU4013397A (en) Arylalkanoylpyridazines
AU6721696A (en) Cd44-like protein
AU2684197A (en) Handleset
AU4480697A (en) Human nm23-like protein
AU2090897A (en) Hydroxyhexahydropyridazines
AU3130597A (en) Tristetraprolin
AUPN745096A0 (en) Novel amp activated protein kinase
AU1750997A (en) Obesity protein formulations
AU3640397A (en) Ob protein binding protein
AU1705197A (en) Obesity protein formulations
AU2243997A (en) Obesity protein formulations
AU1747297A (en) Obesity protein formulations
AU2237197A (en) Fishing-lure
AU1900097A (en) Cremators
AU4586497A (en) Calcium-integrin binding protein
AU4167297A (en) Use of mutated macrolide binding protein for the prevention of guhd
AU1597197A (en) Thienoquinolines
AU3557397A (en) Double-tau-profile
AU4160597A (en) Protein formulations